Lorne Steinberg Brookfield Reinsurance BNRE-T DON'T BUY May 07, 2024

Unfortunately, Brookfield is looking like the old Brascan empire, a plate of spaghetti, where they spin off all these entities, then buy them back and it's hard to keep track of how many there are. That said, BAM and BN-T are grossly undervalued. The market is overreacting to the impact of commercial real estate BN-T, in particular. Do the swap.

It's done extremely well since the company made a major change in 2023 and has exceeded expectations. Almost no dividend, so returns are in the share price. This will continue to do well though now in a consolidation pattern. Good to own.